Discussion | Closing the Disparity in Research

Sunday, March 9, 2025

2:56 PM – 3:15 PM ET

Moderator(s)

Wayne Batchelor, MD, MHS

Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi USA: Consulting Fees (e.g., advisory boards) (Ongoing)
Quinn Capers, IV, MD

Professor and Chair, Dept of Medicine
Howard University College of Medicine
Washington, District of Columbia, United States

Disclosure information not submitted.
Spencer B. King, III, MD, MACC, MSCAI

Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States

Disclosure(s): No financial relationships to disclose
Karol Watson, MD, PhD

Attending Cardiologist
Ronald Reagan UCLA Medical Center
David Geffen School of Medicine at UCLA
Redondo Beach, California, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Farshad Forouzandeh, MD, PhD

Associate Professor of Medicine, Interventional Cardiologist
Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Steven L. Goldberg, MD, FSCAI, FACC

Interventional Cardiologist
SL Goldberg MD A Medical Corporation
Monterey, California, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing); Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech: Consulting Fees (e.g., advisory boards) (Ongoing)
Michael A. Kutcher, MD

Professor Emeritus of Cardiovascular Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States

Disclosure(s): No financial relationships to disclose
Biljana Parapid, MD, PhD

Assistant Professor, Department of Medicine - Cardiology
Belgrade University School of Medicine
Belgrade, Serbia

Disclosure information not submitted.
Dawn C. Scantlebury, MBBS, DM

Consultant Cardiologist
Queen Elizabeth Hospital, Barbados
Haggatt Hall, Saint Michael, Barbados

Disclosure information not submitted.
Ernest Spitzer, MD

Chief Executive Officer
Cardialysis B.V.
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)

Disclosure(s):

Wayne Batchelor, MD, MHS: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi USA: Consulting Fees (e.g., advisory boards) (Ongoing)

Spencer B. King, MD, MACC, MSCAI, III: No financial relationships to disclose

Karol Watson, MD, PhD: No financial relationships to disclose

Farshad Forouzandeh, MD, PhD: No financial relationships to disclose

Steven L. Goldberg, MD, FSCAI, FACC: Abbott Labs: Consultant (Ongoing); Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech: Consulting Fees (e.g., advisory boards) (Ongoing)

Michael A. Kutcher, MD: No financial relationships to disclose

Ernest Spitzer, MD: Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)